Learn More
Gibco™ Human Skeletal Myoblasts (HSkM)
Human Skeletal Myoblasts
Supplier: Gibco™ A11440
Description
Primary Normal Human Skeletal Myoblasts (HSkM) are designed to undergo highly efficient differentiation directly following plating of cryopreserved cells. Each vial contains cells that have been cryopreserved in a medium containing 10% DMSO and will differentiate within 48 hours after plating. These cells do not require expansion prior to differentiation. Cell viability is >70% post thaw with a ≥50% myogenic index after 48 hours. Intended for use by researchers investigating the molecular and biochemical bases of various normal and disease processes. They are compatible with Bacmam delivery technologies for various downstream applications. Large size contains 4.5 x 10^6 ≤ N ≤ 7.5 x 10^6 cells per vial and small size contains 1.1 x 10^6 ≤ N ≤ 1.9 x 10^6 cells per vial.
Primary Normal Human Skeletal Myoblasts (HSkM) are designed to undergo highly efficient differentiation following plating of cryopreserved cells.
The cells are:
- Performance tested—guaranteed to differentiate ≥ 50% following 48 hours of incubation
- Guaranteed to be ≥ 70% viable
- Tested for mycoplasma, bacteria, yeast or other fungi, hepatitis B, hepatitis C, and HIV-1 viruses
Each vial contain sufficient number of cells to fully seed a single multi-well dish (ranging in format from 6-well to 384-well).
Specifications
Store in liquid nitrogen. | |
Skeletal Muscle Cells | |
Cryopreserved | |
Human | |
Single Donor | |
5 x 10^6 | |
Human Skeletal Myoblast | |
Mycoplasma, Bacteria, Yeast or Other Fungi, Hepatitis B, Hepatitis C, HIV-1 Virus |
Adult | |
Adherent Cell Culture | |
Mixed Gender | |
Normal | |
Vial | |
Gibco™ | |
1 vial x 5x106 cells |
For Research Use Only. Not for use in diagnostic procedures.